Liquefied-CO₂ Shipping-Chain Board Examiner

The mandate

The venture is moving from an anchor-source demonstration to a multi-emitter service in which contracted annual tonnes conceal difficult operating concurrency. One customer may nominate a parcel before liquefaction storage is ready; another may deliver composition near an agreed boundary; a carrier delay can consume terminal ullage needed by the next ship; and an injection interruption can strand accepted liquid across vessel and shore tanks. Commercial papers treat capture availability, ship capacity, terminal receipt and subsurface injection as one continuous number even though each has a different decision owner, usable buffer and recovery clock. The board needs to know which customer promises remain executable when two constraints occur together.

Evidence service follows five physical decision blocks rather than a generic monthly calendar. Two blocks examine emitter release and loading, two follow terminal receipt and a carrier turn, and the fifth runs an integrated late-vessel, off-spec parcel and curtailed-injection exercise. Seven committee sessions are included across those blocks. Between them, one reserved day each month lets the examiner reconcile the live nomination, tank and injection case, prepare the chair’s questions and track the resulting condition. A newly reported composition rejection, berth loss or injection interruption receives initial board questions within twenty-four hours and a reasoned challenge within three Norwegian business days; the examiner never enters dispatch or incident command.

The appointment runs eleven months through two customer-onboarding decisions, the annual shipping-and-injection capacity allocation and the integrated interruption exercise. It closes with a gross-to-usable chain bridge, parcel and buffer archetypes, concurrence cases, evidence gates, unresolved contractual dependencies, conflict record and the next board challenge calendar. One additional month may be approved only if a named cross-border permission or injection authorisation changes after the final scheduled committee session; total service cannot exceed twelve months. Restricted shares continue releasing only under their existing shareholder-approved quarterly terms and never because more tonnes are contracted or injected.

The examiner has no line authority, executive responsibility, vessel role, terminal operating duty, technical approval, regulatory standing or board vote. Emitters and authorised laboratories establish release evidence; carrier operators and masters govern vessel acceptance and navigation; terminal officers control receipt and storage; qualified storage operators decide conditioning and injection; public authorities exercise statutory powers; management negotiates customers and schedules the service. The examiner may challenge how those decisions combine, quantify the buffer consumed by uncertainty and recommend board conditions, but cannot approve composition, nominate a ship, accept a parcel, direct a transfer, order injection, allocate customer capacity or certify permanent storage.

Relationships with capture developers, emitters, liquefaction licensors, laboratories, shipowners, yards, cargo-system suppliers, terminals, storage operators, pipeline or well contractors, certification bodies, insurers, commodity traders, governments or investors require disclosure. An active role touching a reviewed customer, vessel, terminal train or storage licence triggers recusal from the whole chain case, not merely its commercial paper. Outside work may continue only behind recorded information barriers. Retainer and shares remain independent of customer accession, transported volume, injection uptime, subsidy, contract award, project valuation, environmental claim or future implementation work.

Why the board wants this voice

Emitter teams understand capture, marine teams understand parcels and storage specialists understand injection, yet each presents capacity inside its own boundary. The investment decision turns on the waiting, conditioning and recovery space between them. Directors want a practitioner who can expose false annual-tonnage confidence and disputed custody without becoming a shadow terminal manager, master, subsurface approver or carbon-accounting assurer.

What you will own

• Press management to trace each nominated parcel through emitter release, liquefaction tank, loading acceptance, custody meter, vessel voyage, terminal receipt, conditioning, injection nomination and accepted storage event.
• Reconcile annual contracted tonnes to usable chain capacity after parcel size, composition hold, tank heel, berth time, vessel cycle, weather, unloading rate, conditioning loss and injection restriction.
• Challenge customer-onboarding cases that assume another emitter, carrier or storage user will provide undeclared flexibility during late delivery, rejection, scrub or maintenance.
• Test whether composition, pressure, temperature, quantity and custody evidence remain attributable when material changes tank, mixes within an authorised envelope or waits through interruption.
• Examine board options for nomination change, delayed loading, temporary hold, vessel resequence, controlled return, injection deferral and customer curtailment without directing any live operation.
• Run the integrated late-vessel, off-spec and injection-curtailment exercise, preserving missing evidence, authority boundaries, dissent, last responsible decision times and customer consequence.
• Leave the committee a usable-capacity bridge, parcel archetypes, buffer cases, decision conditions, conflict register and annual shipping-and-injection challenge agenda.

Candidate qualifications

• Held senior accountability for liquefied-CO₂, cryogenic-gas, specialist bulk-liquid or comparable multi-user maritime transport and terminal operations.
• Has converted annual contracted volume into parcel, vessel, shore-tank and downstream-throughput decisions under concurrent customer demand.
• Understands emitter release, liquid-cargo condition, loading and custody measurement, carrier turns, intermediate storage, conditioning, injection nominations and controlled rejection routes.
• Has challenged an apparently available terminal buffer after tank heel, composition segregation, berth occupancy, vessel delay or downstream outage made it unusable.
• Can preserve laboratory, master, terminal, storage, regulatory and commercial authority while giving directors an integrated physical-capacity judgement.
• Is independent of material emitters, capture vendors, shipowners, terminals, storage operators, laboratories, insurers, contractors and investors in the reviewed chain.

Non-negotiables

• Can provide one evidence day monthly and five two-day blocks spanning seven committee sessions, two emitter observations, two terminal-and-vessel reviews and one integrated exercise.
• Will not approve composition, command a vessel, accept cargo, direct terminal transfer, order injection, allocate customer capacity or certify carbon storage.
• Brings direct liquefied-gas maritime-chain or CCS transport-and-storage operating depth; carbon strategy or conventional shipping finance alone is insufficient.
• Will disclose emitter, technology, laboratory, shipowner, terminal, storage, contractor, insurer, public-funding and investor relationships before evidence access.

1. 49 words maximum. Which hidden tank, parcel or injection constraint most reduced a bulk-liquid shipping chain’s stated annual capacity?
2. 49 words maximum. Where should custody and condition evidence transfer when accepted liquid waits through a downstream interruption?
3. 49 words maximum. What emitter, carrier, terminal, storage, laboratory, insurer or investor interest requires disclosure here?